MX2010008308A - Tratamiento para trastornos relacionados con los ojos. - Google Patents
Tratamiento para trastornos relacionados con los ojos.Info
- Publication number
- MX2010008308A MX2010008308A MX2010008308A MX2010008308A MX2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- ocular
- related disorders
- macular degeneration
- diabetic
- Prior art date
Links
- 208000002780 macular degeneration Diseases 0.000 abstract 2
- 206010012688 Diabetic retinal oedema Diseases 0.000 abstract 1
- 206010012689 Diabetic retinopathy Diseases 0.000 abstract 1
- 206010064930 age-related macular degeneration Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000011190 diabetic macular edema Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
(Ver fórmula (I)) Se describe un tratamiento para trastornos relacionados con los ojos, tales como la degeneración macular, y preferentemente degeneración macular asociada a la edad, retinopatía diabética, y edema macular diabético, utilizando un compuesto de Fórmula 1.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3507308P | 2008-03-10 | 2008-03-10 | |
| PCT/US2009/036119 WO2009114373A1 (en) | 2008-03-10 | 2009-03-05 | Treatment for ocular-related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010008308A true MX2010008308A (es) | 2010-08-11 |
Family
ID=40583469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010008308A MX2010008308A (es) | 2008-03-10 | 2009-03-05 | Tratamiento para trastornos relacionados con los ojos. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP2285378A1 (es) |
| JP (1) | JP2011513488A (es) |
| KR (1) | KR20110009084A (es) |
| CN (1) | CN101965188A (es) |
| AR (1) | AR070975A1 (es) |
| AU (1) | AU2009223501A1 (es) |
| BR (1) | BRPI0909659A2 (es) |
| CA (1) | CA2717991A1 (es) |
| CL (1) | CL2009000551A1 (es) |
| CO (1) | CO6290691A2 (es) |
| CR (1) | CR11644A (es) |
| DO (1) | DOP2010000266A (es) |
| IL (1) | IL207906A0 (es) |
| MA (1) | MA32211B1 (es) |
| MX (1) | MX2010008308A (es) |
| NI (1) | NI201000131A (es) |
| NZ (1) | NZ587906A (es) |
| RU (1) | RU2010141560A (es) |
| SV (1) | SV2010003658A (es) |
| TW (1) | TW200950784A (es) |
| WO (1) | WO2009114373A1 (es) |
| ZA (1) | ZA201005337B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR074776A1 (es) | 2008-12-18 | 2011-02-09 | Sanofi Aventis | Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente |
| EP2441755A1 (en) | 2010-09-30 | 2012-04-18 | Almirall, S.A. | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors |
| EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1050191B (en) * | 1999-12-24 | 2011-04-29 | Aventis Pharma Limited | Azaindoles |
| CA2400923A1 (en) * | 2000-02-25 | 2001-08-30 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| NZ567241A (en) * | 2005-09-30 | 2010-08-27 | Miikana Therapeutics Inc | Substituted pyrazole compounds |
| CL2007002617A1 (es) * | 2006-09-11 | 2008-05-16 | Sanofi Aventis | Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto. |
-
2009
- 2009-03-05 NZ NZ587906A patent/NZ587906A/en not_active IP Right Cessation
- 2009-03-05 EP EP09718970A patent/EP2285378A1/en not_active Withdrawn
- 2009-03-05 RU RU2010141560/15A patent/RU2010141560A/ru unknown
- 2009-03-05 WO PCT/US2009/036119 patent/WO2009114373A1/en not_active Ceased
- 2009-03-05 AU AU2009223501A patent/AU2009223501A1/en not_active Abandoned
- 2009-03-05 MX MX2010008308A patent/MX2010008308A/es not_active Application Discontinuation
- 2009-03-05 CN CN2009801075816A patent/CN101965188A/zh active Pending
- 2009-03-05 KR KR1020107019973A patent/KR20110009084A/ko not_active Withdrawn
- 2009-03-05 JP JP2010550758A patent/JP2011513488A/ja not_active Withdrawn
- 2009-03-05 BR BRPI0909659A patent/BRPI0909659A2/pt not_active IP Right Cessation
- 2009-03-05 CA CA2717991A patent/CA2717991A1/en not_active Abandoned
- 2009-03-09 CL CL2009000551A patent/CL2009000551A1/es unknown
- 2009-03-09 TW TW098107567A patent/TW200950784A/zh unknown
- 2009-03-09 AR ARP090100835A patent/AR070975A1/es not_active Application Discontinuation
-
2010
- 2010-07-27 ZA ZA2010/05337A patent/ZA201005337B/en unknown
- 2010-07-29 NI NI201000131A patent/NI201000131A/es unknown
- 2010-08-24 CR CR11644A patent/CR11644A/es not_active Application Discontinuation
- 2010-08-31 IL IL207906A patent/IL207906A0/en unknown
- 2010-09-01 CO CO10108103A patent/CO6290691A2/es not_active Application Discontinuation
- 2010-09-02 DO DO2010000266A patent/DOP2010000266A/es unknown
- 2010-09-07 SV SV2010003658A patent/SV2010003658A/es unknown
- 2010-10-06 MA MA33226A patent/MA32211B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR070975A1 (es) | 2010-05-19 |
| CR11644A (es) | 2010-11-22 |
| NI201000131A (es) | 2011-09-29 |
| KR20110009084A (ko) | 2011-01-27 |
| TW200950784A (en) | 2009-12-16 |
| EP2285378A1 (en) | 2011-02-23 |
| WO2009114373A1 (en) | 2009-09-17 |
| MA32211B1 (fr) | 2011-04-01 |
| SV2010003658A (es) | 2011-01-31 |
| NZ587906A (en) | 2011-12-22 |
| DOP2010000266A (es) | 2010-09-30 |
| JP2011513488A (ja) | 2011-04-28 |
| ZA201005337B (en) | 2011-04-28 |
| RU2010141560A (ru) | 2012-04-20 |
| CO6290691A2 (es) | 2011-06-20 |
| CN101965188A (zh) | 2011-02-02 |
| AU2009223501A1 (en) | 2009-09-17 |
| BRPI0909659A2 (pt) | 2015-09-22 |
| IL207906A0 (en) | 2010-12-30 |
| CA2717991A1 (en) | 2009-09-17 |
| CL2009000551A1 (es) | 2009-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY175318A (en) | Androgen composition for treating an opthalmic condition | |
| EA201590053A1 (ru) | Модуляторы пути системы комплемента и их применение | |
| HK1201438A1 (en) | Treatment of ocular disease | |
| GEP201706695B (en) | Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases | |
| PH12014500281A1 (en) | Compounds as tyrosine kinase modulators | |
| MX358176B (es) | El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la córnea. | |
| JO3039B1 (ar) | طريقة ومركب لعلاج فرط ضغط العين والجلوكوما | |
| WO2012080497A3 (en) | Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases | |
| EP3542629A3 (en) | Dithiol compounds, derivatives, and uses therefor | |
| MX2009003316A (es) | Derivados de pirazina-2-carboxamida como moduladores receptores de cb2. | |
| MX2015007916A (es) | Peri-carbinoles. | |
| WO2007098122A3 (en) | Methods for the treatment of macular degeneration and related eye conditions | |
| EA201490721A1 (ru) | Лекарственное средство для лечения заболеваний передней камеры глаза, включающее ребамипид и агент, удерживающий слезы | |
| WO2009074247A8 (de) | Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel | |
| GEP20156315B (en) | Oxazoline and isoxazoline derivatives as crac modulators | |
| IN2012DN03846A (es) | ||
| NZ597866A (en) | Therapeutic lactams | |
| WO2009109501A3 (en) | Ocular pharmaceutical compositions | |
| WO2007089673A3 (en) | Compositions and methods for treatment of ophthalmic diseases and disorders | |
| MX2014003883A (es) | Inhibidores de monoacilglicerol lipasa para el tratamiento de enfermedades metabolicas y transtornos relacionados. | |
| MX2010008308A (es) | Tratamiento para trastornos relacionados con los ojos. | |
| WO2008124151A3 (en) | Use of creatine compounds for the treatment of eye disorders | |
| WO2010046865A3 (en) | Ophthalmic administration of a composition including brimonidine as a mist | |
| TN2010000368A1 (en) | Treatment for ocular-related disorders | |
| TW200744627A (en) | Methods for the treatment of macular degeneration and related eye conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |